Previous close | 4.94 |
Open | 4.98 |
Bid | 5.09 x 100 |
Ask | 5.14 x 100 |
Day's range | 4.94 - 5.16 |
52-week range | 1.11 - 6.72 |
Volume | |
Avg. volume | 1,428,278 |
Market cap | 581.247M |
Beta (5Y monthly) | 2.39 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The focus is likely to be on progress on its pipeline candidates when generative AI drug creation company Absci (ABSI) reports first-quarter results.
CytomX Therapeutics (CTMX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Absci Corporation (ABSI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.